SCHEMBL16349409

SCHEMBL16349409

CN(Cl)CCOC(c1ccccc1)c1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 7/20 0.73
SLC6A4 P31645 7/20 0.73
SLC6A3 Q01959 7/20 0.73
LMNA P02545 3/20 0.73
CHRM2 P08172 3/20 0.73
ADRA2A P08913 3/20 0.73
CHRM1 P11229 3/20 0.73
OPRM1 P35372 3/20 0.73
DRD3 P35462 3/20 0.73
CYP2D6 P10635 3/20 0.73
SCN1A P35498 3/20 0.73
SCN2A Q99250 3/20 0.73
SCN3A Q9NY46 3/20 0.73
CHRM4 P08173 2/20 0.73
CHRM5 P08912 2/20 0.73
ADRA2B P18089 2/20 0.73
CHRM3 P20309 2/20 0.73
HRH2 P25021 2/20 0.73
HTR2A P28223 2/20 0.73
HTR2C P28335 2/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL637495 0.86 SLC6A2 (0.78) SLC6A2SLC6A4SLC6A3LMNACHRM2
Diphenhydramine SCHEMBL4064 0.85 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3LMNACHRM2
Diphenhydramine SCHEMBL12543374 0.85 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3LMNACHRM2
Diphenhydramine SCHEMBL28210970 0.83 SLC6A2 (0.96) SLC6A2SLC6A4SLC6A3LMNACHRM2
Diphenhydramine SCHEMBL29205078 0.83 SLC6A2 (0.96) SLC6A2SLC6A4SLC6A3LMNACHRM2
Diphenhydramine SCHEMBL25219551 0.83 SLC6A2 (0.96) SLC6A2SLC6A4SLC6A3LMNACHRM2
Diphenhydramine SCHEMBL10487818 0.83 LMNA (1.00) SLC6A2SLC6A4SLC6A3LMNACHRM2
Diphenhydramine SCHEMBL9565209 0.83 SLC6A2 (0.96) SLC6A2SLC6A4SLC6A3LMNACHRM2
Diphenhydramine SCHEMBL17071 0.83 LMNA (1.00) SLC6A2SLC6A4SLC6A3LMNACHRM2
Diphenhydramine SCHEMBL11795332 0.83 SLC6A2 (0.96) SLC6A2SLC6A4SLC6A3LMNACHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410975-B2 Small molecule toll-like receptor (TLR) antagonists COLEY PHARMACEUTICAL GROUP, INC. (US) 2008-08-12 US disclosed